SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL
Delisted
SEEL was delisted on the 15th of October, 2024.
60 hedge funds and large institutions have $125M invested in Seelos Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less call options, than puts
Call options by funds: $837K | Put options by funds: $1.67M
Holders
60
Holding in Top 10
2
Calls
$837K
Puts
$1.67M
Top Buyers
| 1 | +$17.3M | |
| 2 | +$10.8M | |
| 3 | +$9.43M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$8.58M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$7.22M |
Top Sellers
| 1 | -$1.99M | |
| 2 | -$1.11M | |
| 3 | -$659K | |
| 4 |
1CM
1492 Capital Management
Milwaukee,
Wisconsin
|
-$188K |
| 5 |
VF
Virtu Financial
New York
|
-$134K |